Effect of beta-blocker therapy in elderly patients with dilated cardiomyopathy

Circulation Journal

Volumn 67, Issue 10, 2003, Pages 826-829

  Hara, Yuji ^a   Hamada, Mareomi ^a   Shigematsu, Yuji ^a   Ohtsuka, Tomoaki ^a   Ogimoto, Akiyoshi ^a   Suzuki, Jun ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Beta blockers; Dilated cardiomyopathy; Elderly patients; Natriuretic peptides

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEVANTOLOL; CARVEDILOL; METOPROLOL; NATRIURETIC FACTOR;

ADULT; AGE; AGED; ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; FEMALE; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; CARDIOMYOPATHY, DILATED; HEART FUNCTION TESTS; HEART VENTRICLES; HEMODYNAMIC PHENOMENA; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDES; SEX FACTORS; STROKE VOLUME;

EID: 0141926591     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.826     Document Type: Article

References (19)

1. Waagstein F, Hjalmarson Å, Varnaukas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-1036.
2. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441-1446.
3. Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995; 92: 1499-1506.
4. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
5. CIBIS II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial. Lancet 1999; 353: 9-13.
6. Hirooka K, Yasumura Y, Ishida Y, Hanatani A, Nakatani S, Komamura K, et al. Comparative left ventricular functional and neurohormoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy. Jpn Circ J 2001; 65: 931-936.
7. Hara Y, Hamada M, Ohtsuka T, Ogimoto A, Saeki H, Suzuki J, et al. Use of thallium-201 myocardial scintigraphy for prediction of the response to β-blocker therapy in patients with dilated cardiomyopathy. Circ J 2002; 66: 1139-1143.
8. Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
9. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode Standardization of The American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
10. Hamada M, Shigematsu Y, Kawakami H, Minamino N, Kangawa K, Matsuo H, et al. Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: Its relation to endothelin-1, natriuretic peptides and noradrenaline. Clin Sci 1998; 94: 21-28.
11. Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181-186.
12. Fleg JL, Schulman S, O'Connor F, Becker LC, Gerstenblith G, Clulow JF, et al. Effects of acute beta-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. Circulation 1994; 90: 2333-2341.
13. Taneja T, Mahnert BW, Passman R, Goldberger J, Kadish A. Effects of sex and age on electrocardiographic and cardiac electrophysiological properties in adults. Pacing Clin Electrophysiol 2001; 24: 16-21.
14. Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
15. Aranda JM, Krause-Steinrauf HJ, Greenberg BH, Heng MK, Kosolcharoen PK, Renlund DG, et al. Comparison of the beta blocker bucindolol in younger vs older patients with heart failure. Am J Cardiol 2002; 89: 1322-1326.
16. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.
17. Davis KM, Fish LC, Minaker KL, Elahi D. Atrial natriuretic peptide levels in the elderly: Differentiating normal aging changes from disease. J Gerontol A Biol Sci Med Sci 1996; 51: M95-M101.
18. Sayama H, Nakamura Y, Saito N, Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis 1999; 10: 537-540.
19. Hara Y, Hamada M, Ohtsuka T, Ogimoto A, Saeki H, Matsunaka T, et al. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy. Heart Vessel 2002; 17: 53-56.